152 related articles for article (PubMed ID: 34426152)
21. Synthesis and biological evaluation of 3-aminoisoquinolin-1(2H)-one based inhibitors of the dual-specificity phosphatase Cdc25B.
George Rosenker KM; Paquette WD; Johnston PA; Sharlow ER; Vogt A; Bakan A; Lazo JS; Wipf P
Bioorg Med Chem; 2015 Jun; 23(12):2810-8. PubMed ID: 25703307
[TBL] [Abstract][Full Text] [Related]
22. Medicinal chemistry insights into novel CDC25 inhibitors.
Tao Y; Hao X; Ding X; Cherukupalli S; Song Y; Liu X; Zhan P
Eur J Med Chem; 2020 Sep; 201():112374. PubMed ID: 32603979
[TBL] [Abstract][Full Text] [Related]
23. Novel coumarin- and quinolinone-based polycycles as cell division cycle 25-A and -C phosphatases inhibitors induce proliferation arrest and apoptosis in cancer cells.
Zwergel C; Czepukojc B; Evain-Bana E; Xu Z; Stazi G; Mori M; Patsilinakos A; Mai A; Botta B; Ragno R; Bagrel D; Kirsch G; Meiser P; Jacob C; Montenarh M; Valente S
Eur J Med Chem; 2017 Jul; 134():316-333. PubMed ID: 28431339
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases.
Evain-Bana E; Schiavo L; Bour C; Lanfranchi DA; Berardozzi S; Ghirga F; Bagrel D; Botta B; Hanquet G; Mori M
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):113-118. PubMed ID: 27774816
[TBL] [Abstract][Full Text] [Related]
25. Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase.
Brisson M; Nguyen T; Vogt A; Yalowich J; Giorgianni A; Tobi D; Bahar I; Stephenson CR; Wipf P; Lazo JS
Mol Pharmacol; 2004 Oct; 66(4):824-33. PubMed ID: 15231869
[TBL] [Abstract][Full Text] [Related]
26. Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism, and in Vitro Efficacy against Melanoma Cell Lines.
Cerchia C; Nasso R; Mori M; Villa S; Gelain A; Capasso A; Aliotta F; Simonetti M; Rullo R; Masullo M; De Vendittis E; Ruocco MR; Lavecchia A
J Med Chem; 2019 Aug; 62(15):7089-7110. PubMed ID: 31294975
[TBL] [Abstract][Full Text] [Related]
27. Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.
Mak LH; Knott J; Scott KA; Scott C; Whyte GF; Ye Y; Mann DJ; Ces O; Stivers J; Woscholski R
Bioorg Med Chem; 2012 Jul; 20(14):4371-6. PubMed ID: 22705189
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms.
Brenner AK; Reikvam H; Lavecchia A; Bruserud Ø
Molecules; 2014 Nov; 19(11):18414-47. PubMed ID: 25397735
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases.
Brezak MC; Quaranta M; Contour-Galcera MO; Lavergne O; Mondesert O; Auvray P; Kasprzyk PG; Prevost GP; Ducommun B
Mol Cancer Ther; 2005 Sep; 4(9):1378-87. PubMed ID: 16170030
[TBL] [Abstract][Full Text] [Related]
30. Discovery of Cdc25A Lead Inhibitors with a Novel Chemotype by Virtual Screening: Application of Pharmacophore Modeling Based on a Training Set with a Limited Number of Unique Components.
Ge YS; Han QQ; Duan W; Zhang JQ; Chen K; Wan JJ; Liu Y; Liu D
ChemMedChem; 2017 Mar; 12(6):438-447. PubMed ID: 28198152
[TBL] [Abstract][Full Text] [Related]
31. Cdc25B phosphatase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective.
Lavecchia A; Coluccia A; Di Giovanni C; Novellino E
Anticancer Agents Med Chem; 2008 Dec; 8(8):843-56. PubMed ID: 19075567
[TBL] [Abstract][Full Text] [Related]
32. Syntheses and biological activities of a novel group of steroidal derived inhibitors for human Cdc25A protein phosphatase.
Peng H; Xie W; Otterness DM; Cogswell JP; McConnell RT; Carter HL; Powis G; Abraham RT; Zalkow LH
J Med Chem; 2001 Mar; 44(5):834-48. PubMed ID: 11262093
[TBL] [Abstract][Full Text] [Related]
33. Shikonin inhibits cancer cell cycling by targeting Cdc25s.
Zhang S; Gao Q; Li W; Zhu L; Shang Q; Feng S; Jia J; Jia Q; Shen S; Su Z
BMC Cancer; 2019 Jan; 19(1):20. PubMed ID: 30616572
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review.
Lavecchia A; Di Giovanni C; Novellino E
Expert Opin Ther Pat; 2010 Mar; 20(3):405-25. PubMed ID: 20166845
[TBL] [Abstract][Full Text] [Related]
35. Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells.
Brault L; Bagrel D
Life Sci; 2008 Jan; 82(5-6):315-23. PubMed ID: 18191419
[TBL] [Abstract][Full Text] [Related]
36. A novel cinnamic acid derivative that inhibits Cdc25 dual-specificity phosphatase activity.
Aoyagi Y; Masuko N; Ohkubo S; Kitade M; Nagai K; Okazaki S; Wierzba K; Terada T; Sugimoto Y; Yamada Y
Cancer Sci; 2005 Sep; 96(9):614-9. PubMed ID: 16128747
[TBL] [Abstract][Full Text] [Related]
37. The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches.
Li HL; Ma Y; Ma Y; Li Y; Chen XB; Dong WL; Wang RL
Oncotarget; 2017 May; 8(20):33225-33240. PubMed ID: 28402259
[TBL] [Abstract][Full Text] [Related]
38. CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy.
Lavecchia A; Di Giovanni C; Novellino E
Curr Med Chem; 2009; 16(15):1831-49. PubMed ID: 19442149
[TBL] [Abstract][Full Text] [Related]
39. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
Park H; Li M; Choi J; Cho H; Ham SW
Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
[TBL] [Abstract][Full Text] [Related]
40. Rapid discovery of triazolobenzylidene-thiazolopyrimidines (TBTP) as CDC25 phosphatase inhibitors by parallel click chemistry and in situ screening.
Duval R; Kolb S; Braud E; Genest D; Garbay C
J Comb Chem; 2009; 11(6):947-50. PubMed ID: 19835352
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
